NYSE : SNN
Smith & Nephew plc — Key statistics
Healthcare · Medical Devices · United Kingdom
Last price 29.925 USD (Oct 30, 2026, 10:01 AM EDT) · Market cap 12.35B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 12.64B |
| Enterprise Value | 15.71B |
Dates
| Measure | Value |
|---|
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | Oct 2, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | n/a |
| Shares Outstanding | 851.12M |
| Shares Change (YoY) | -1.79% |
| Shares Change (QoQ) | -0.61% |
| Owned by Insiders (%) | 0.13% |
| Owned by Institutions (%) | 90.09% |
| Float | 828.70M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 20.27 |
| Forward PE | 13.35 |
| PS Ratio | 1.97 |
| Forward PS | 1.88 |
| PB Ratio | 2.40 |
| P/TBV Ratio | 14.86 |
| P/FCF Ratio | 14.52 |
| P/OCF Ratio | 9.27 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 24.39 |
| EV / Sales | 2.46 |
| EV / EBITDA | 11.21 |
| EV / EBIT | 17.29 |
| EV / FCF | 18.11 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.14 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | 2.65 |
| Debt / FCF | 4.43 |
| Interest Coverage | 6.59 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 11.85% |
| Return on Assets (ROA) | 5.16% |
| Return on Invested Capital (ROIC) | 8.69% |
| Return on Capital Employed (ROCE) | 10.00% |
| Weighted Average Cost of Capital (WACC) | 6.75% |
| Revenue Per Employee | $370,850 |
| Profits Per Employee | $37,379 |
| Employee Count | 16,988 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 0.87 |
Taxes
| Measure | Value |
|---|
| Income Tax | 162.00M |
| Effective Tax Rate | 20.33% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -17.80% |
| 50-Day Moving Average | 28.33 |
| 200-Day Moving Average | 31.05 |
| Relative Strength Index (RSI) | 62.56 |
| Average Volume (20 Days) | 1,207,208 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.04M |
| Short Previous Month | 4.83M |
| Short % of Shares Out | 0.97% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.23 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 6.30B |
| Gross Profit | 4.31B |
| Operating Income | 896.00M |
| Pretax Income | 797.00M |
| Net Income | 635.00M |
| EBITDA | 1.38B |
| EBIT | 896.00M |
| Earnings Per Share (EPS) | $1.49 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 754.00M |
| Total Debt | 3.79B |
| Net Cash | -3.03B |
| Net Cash Per Share | -$3.56 |
| Equity (Book Value) | 5.18B |
| Book Value Per Share | 6.09 |
| Working Capital | 2.34B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.34B |
| Capital Expenditures | -484.00M |
| Depreciation & Amortization | 486.00M |
| Net Borrowing | 360.00M |
| Free Cash Flow | 855.00M |
| FCF Per Share | $1.00 |
Margins
| Measure | Value |
|---|
| Gross Margin | 68.44% |
| Operating Margin | 14.22% |
| Pretax Margin | 12.65% |
| Profit Margin | 10.08% |
| EBITDA Margin | 21.94% |
| EBIT Margin | 14.22% |
| FCF Margin | 13.57% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.76 |
| Dividend Yield | 2.53% |
| Dividend Growth (YoY) | 4.37% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 51.23% |
| FCF Payout Ratio | 76.05% |
| Buyback Yield | 1.79% |
| Shareholder Yield | 4.33% |
| Earnings Yield | 4.93% |
| FCF Yield | 6.89% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $32.32 |
| Price Target Difference | 6.88% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 5.10% |
| EPS Growth Forecast (3Y) | 9.12% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 15, 2014 |
| Split Type | Forward |
| Split Ratio | 2.5:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.26 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |